Nuveen Asset Management, LLC Revance Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 455,313 shares of RVNC stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
455,313
Previous 1,056,062
56.89%
Holding current value
$1.17 Million
Previous $2.71 Million
56.89%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding RVNC
# of Institutions
234Shares Held
82.8MCall Options Held
680KPut Options Held
896K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.73MShares$14.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.78MShares$12.3 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.19MShares$10.8 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ4.16MShares$10.7 Million0.49% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...